NBY logo

NovaBay Pharmaceuticals (NBY) Cash From Investing

Annual CFI

-$19.00 K
+$93.00 K+83.04%

December 1, 2023

Summary

Performance

1-Year Change

+83.04%

3-Year Change

+26.92%

5-Year Change

+56.82%

15-Year Change

+92.21%

NBY Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

61.35%
NBY annual cash flow from investing activities is higher than 61.35% of companies in Healthcare sector

High & Low

All-time High

$10.86 M
NBY annual cash flow from investing activities is currently -100.17% below its historical high of $10.86 million

3-Year Low

-$12.04 M

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
NBY previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

N/A
NBY next annual earnings announcement has not yet been scheduled

OtherNBYcash flowmetrics:

Annual CFF

$1.91 M
NBY annual cash flow from financing activities is $1.91 million

Annual CFO

-$4.13 M
NBY annual cash flow from operations is -$4.13 million

Annual FCF

-$4.15 M
NBY annual free cash flow is -$4.15 million

Annual CAPEX

$19.00 K
NBY annual capital expenditures is $19.00 thousand

Quarterly CFI

-$2000.00
$0.000.00%

September 1, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

-100%

3-Year Change

0%

5-Year Change

0%

NBY Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

54.99%
NBY quarterly cash flow from investing activities is higher than 54.99% of companies in Healthcare sector

High & Low

All-time High

$3.44 M
NBY quarterly cash flow from investing activities is currently -100.06% below its historical high of $3.44 million

3-Year Low

-$12.00 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
NBY previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
NBY next earnings announcement has not yet been scheduled

OtherNBYcash flowmetrics:

Quarterly CFF

$2.09 M
NBY quarterly cash flow from financing activities is $2.09 million

Quarterly CFO

-$2.06 M
NBY quarterly cash flow from operations is -$2.06 million

Quarterly FCF

-$2.06 M
NBY quarterly free cash flow is -$2.06 million

Quarterly CAPEX

$2000.00
NBY quarterly capital expenditures is $2000.00

TTM CFI

$1.06 M
-$1000.00-0.09%

September 1, 2024

Summary

Performance

3-Month Change

-0.09%

1-Year Change

+6731.25%

3-Year Change

+1216.84%

5-Year Change

+1216.84%

NBY TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

72.37%
NBY TTM cash flow from investing activities is higher than 72.37% of companies in Healthcare sector

High & Low

All-time High

$10.86 M
NBY TTM cash flow from investing activities is currently -90.23% below its historical high of $10.86 million

3-Year Low

-$12.11 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
NBY previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
NBY next earnings announcement has not yet been scheduled

OtherNBYcash flowmetrics:

TTM CFF

$974.00 K
NBY TTM cash flow from financing activities is $974.00 thousand

TTM CFO

-$4.80 M
NBY TTM cash flow from operations is -$4.80 million

TTM FCF

-$4.81 M
NBY TTM free cash flow is -$4.81 million

TTM CAPEX

$9000.00
NBY TTM capital expenditures is $9000.00

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

NBY Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+83.0%-100.0%+6731.3%
3 y3 years+26.9%0.0%+1216.8%
5 y5 years+56.8%0.0%+1216.8%

NBY Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+99.8%-100.2%+100.0%-0.1%+108.8%
5 y5-yearat high+99.8%-100.2%+100.0%-0.1%+108.8%
alltimeall time-100.2%+99.8%-100.1%+100.0%-90.2%+108.8%

NovaBay Pharmaceuticals Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$2000.00(0.0%)
$1.06 M(-0.1%)
Jun 2024
-
-$2000.00(-100.2%)
$1.06 M(0.0%)
Mar 2024
-
$1.07 M(<-9900.0%)
$1.06 M(-5689.5%)
Dec 2023
-$19.00 K(-83.0%)
-$3000.00(+200.0%)
-$19.00 K(+18.8%)
Sep 2023
-
-$1000.00(-50.0%)
-$16.00 K(-83.2%)
Jun 2023
-
-$2000.00(-84.6%)
-$95.00 K(-5.9%)
Mar 2023
-
-$13.00 K(<-9900.0%)
-$101.00 K(-9.8%)
Dec 2022
-$112.00 K(-99.1%)
$0.00(-100.0%)
-$112.00 K(-99.1%)
Sep 2022
-
-$80.00 K(+900.0%)
-$12.11 M(+0.5%)
Jun 2022
-
-$8000.00(-66.7%)
-$12.05 M(+0.0%)
Mar 2022
-
-$24.00 K(-99.8%)
-$12.04 M(-0.0%)
Dec 2021
-$12.04 M(>+9900.0%)
-$12.00 M(>+9900.0%)
-$12.04 M(>+9900.0%)
Sep 2021
-
-$17.00 K(+750.0%)
-$65.00 K(+22.6%)
Jun 2021
-
-$2000.00(-92.0%)
-$53.00 K(+3.9%)
Mar 2021
-
-$25.00 K(+19.0%)
-$51.00 K(+96.2%)
Dec 2020
-$26.00 K(+36.8%)
-$21.00 K(+320.0%)
-$26.00 K(+420.0%)
Sep 2020
-
-$5000.00(<-9900.0%)
-$5000.00(<-9900.0%)
Jun 2020
-
$0.00(0.0%)
$0.00(-100.0%)
Mar 2020
-
$0.00(0.0%)
-$5000.00(-73.7%)
Dec 2019
-$19.00 K(-56.8%)
$0.00(0.0%)
-$19.00 K(-62.0%)
Sep 2019
-
$0.00(-100.0%)
-$50.00 K(-13.8%)
Jun 2019
-
-$5000.00(-64.3%)
-$58.00 K(+3.6%)
Mar 2019
-
-$14.00 K(-54.8%)
-$56.00 K(+27.3%)
Dec 2018
-$44.00 K(-82.0%)
-$31.00 K(+287.5%)
-$44.00 K(+51.7%)
Sep 2018
-
-$8000.00(+166.7%)
-$29.00 K(-69.1%)
Jun 2018
-
-$3000.00(+50.0%)
-$94.00 K(-49.7%)
Mar 2018
-
-$2000.00(-87.5%)
-$187.00 K(-23.4%)
Dec 2017
-$244.00 K(+52.5%)
-$16.00 K(-78.1%)
-$244.00 K(-21.3%)
Sep 2017
-
-$73.00 K(-24.0%)
-$310.00 K(+11.9%)
Jun 2017
-
-$96.00 K(+62.7%)
-$277.00 K(+36.5%)
Mar 2017
-
-$59.00 K(-28.0%)
-$203.00 K(+26.9%)
Dec 2016
-$160.00 K(+86.0%)
-$82.00 K(+105.0%)
-$160.00 K(+3.2%)
Sep 2016
-
-$40.00 K(+81.8%)
-$155.00 K(+11.5%)
Jun 2016
-
-$22.00 K(+37.5%)
-$139.00 K(+11.2%)
Mar 2016
-
-$16.00 K(-79.2%)
-$125.00 K(+45.3%)
Dec 2015
-$86.00 K
-$77.00 K(+220.8%)
-$86.00 K(-106.8%)
DateAnnualQuarterlyTTM
Sep 2015
-
-$24.00 K(+200.0%)
$1.26 M(-66.9%)
Jun 2015
-
-$8000.00(-134.8%)
$3.79 M(-23.3%)
Mar 2015
-
$23.00 K(-98.2%)
$4.95 M(+90.3%)
Dec 2014
$2.60 M(+84.6%)
$1.26 M(-49.7%)
$2.60 M(+1.6%)
Sep 2014
-
$2.51 M(+119.9%)
$2.56 M(+167.4%)
Jun 2014
-
$1.14 M(-149.2%)
$956.00 K(-513.9%)
Mar 2014
-
-$2.32 M(-290.0%)
-$231.00 K(-116.4%)
Dec 2013
$1.41 M(+3.2%)
$1.22 M(+33.8%)
$1.41 M(+130.7%)
Sep 2013
-
$914.00 K(-2177.3%)
$610.00 K(-11.6%)
Jun 2013
-
-$44.00 K(-93.6%)
$690.00 K(+223.9%)
Mar 2013
-
-$686.00 K(-261.0%)
$213.00 K(-84.4%)
Dec 2012
$1.36 M(-129.2%)
$426.00 K(-57.1%)
$1.36 M(-152.5%)
Sep 2012
-
$994.00 K(-290.8%)
-$2.60 M(-43.0%)
Jun 2012
-
-$521.00 K(-212.3%)
-$4.56 M(-0.5%)
Mar 2012
-
$464.00 K(-113.1%)
-$4.58 M(-1.7%)
Dec 2011
-$4.67 M(+290.7%)
-$3.54 M(+265.6%)
-$4.67 M(+340.9%)
Sep 2011
-
-$967.00 K(+77.1%)
-$1.06 M(+60.8%)
Jun 2011
-
-$546.00 K(-242.6%)
-$658.00 K(+200.5%)
Mar 2011
-
$383.00 K(+431.9%)
-$219.00 K(-81.7%)
Dec 2010
-$1.19 M(+11.7%)
$72.00 K(-112.7%)
-$1.19 M(+73.3%)
Sep 2010
-
-$567.00 K(+429.9%)
-$689.00 K(-156.9%)
Jun 2010
-
-$107.00 K(-81.9%)
$1.21 M(+20.4%)
Mar 2010
-
-$592.00 K(-202.6%)
$1.01 M(-194.1%)
Dec 2009
-$1.07 M(-109.8%)
$577.00 K(-56.7%)
-$1.07 M(-162.4%)
Sep 2009
-
$1.33 M(-527.2%)
$1.71 M(-55.2%)
Jun 2009
-
-$312.00 K(-88.3%)
$3.82 M(-36.5%)
Mar 2009
-
-$2.67 M(-179.4%)
$6.01 M(-44.6%)
Dec 2008
$10.86 M(-291.9%)
$3.36 M(-2.4%)
$10.86 M(+431.8%)
Sep 2008
-
$3.44 M(+82.8%)
$2.04 M(-247.7%)
Jun 2008
-
$1.88 M(-13.8%)
-$1.38 M(-57.3%)
Mar 2008
-
$2.18 M(-140.0%)
-$3.24 M(-42.7%)
Dec 2007
-$5.66 M(+2.7%)
-$5.46 M(<-9900.0%)
-$5.66 M(+2758.6%)
Sep 2007
-
$14.00 K(-39.1%)
-$198.00 K(-6.6%)
Jun 2007
-
$23.00 K(-109.8%)
-$212.00 K(-9.8%)
Mar 2007
-
-$235.00 K
-$235.00 K
Dec 2006
-$5.51 M(+382.3%)
-
-
Dec 2005
-$1.14 M
-
-

FAQ

  • What is NovaBay Pharmaceuticals annual cash flow from investing activities?
  • What is the all time high annual CFI for NovaBay Pharmaceuticals?
  • What is NovaBay Pharmaceuticals annual CFI year-on-year change?
  • What is NovaBay Pharmaceuticals quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for NovaBay Pharmaceuticals?
  • What is NovaBay Pharmaceuticals quarterly CFI year-on-year change?
  • What is NovaBay Pharmaceuticals TTM cash flow from investing activities?
  • What is the all time high TTM CFI for NovaBay Pharmaceuticals?
  • What is NovaBay Pharmaceuticals TTM CFI year-on-year change?

What is NovaBay Pharmaceuticals annual cash flow from investing activities?

The current annual CFI of NBY is -$19.00 K

What is the all time high annual CFI for NovaBay Pharmaceuticals?

NovaBay Pharmaceuticals all-time high annual cash flow from investing activities is $10.86 M

What is NovaBay Pharmaceuticals annual CFI year-on-year change?

Over the past year, NBY annual cash flow from investing activities has changed by +$93.00 K (+83.04%)

What is NovaBay Pharmaceuticals quarterly cash flow from investing activities?

The current quarterly CFI of NBY is -$2000.00

What is the all time high quarterly CFI for NovaBay Pharmaceuticals?

NovaBay Pharmaceuticals all-time high quarterly cash flow from investing activities is $3.44 M

What is NovaBay Pharmaceuticals quarterly CFI year-on-year change?

Over the past year, NBY quarterly cash flow from investing activities has changed by -$1000.00 (-100.00%)

What is NovaBay Pharmaceuticals TTM cash flow from investing activities?

The current TTM CFI of NBY is $1.06 M

What is the all time high TTM CFI for NovaBay Pharmaceuticals?

NovaBay Pharmaceuticals all-time high TTM cash flow from investing activities is $10.86 M

What is NovaBay Pharmaceuticals TTM CFI year-on-year change?

Over the past year, NBY TTM cash flow from investing activities has changed by +$1.08 M (+6731.25%)